Raspberry Leaf

Metadata

Approved Indications

Commission E (Germany)

• No specific Commission E monograph in wide circulation for Raspberry Leaf’s pregnancy use
• Traditional uses referenced in German herbalism include gastrointestinal and menstrual complaints

ESCOP

• No ESCOP monograph for Raspberry Leaf pregnancy use

EMA/HMPC

• Status: Traditional Use
• Monograph reference: EMA/HMPC/44211/2012 (January 2014)
• Approved traditional indications:
  1. Relief of spasmodic period pains (menstrual cramps)
  2. Symptomatic relief of minor inflammations in the mouth and throat
  3. Symptomatic treatment of mild diarrhea
• CRITICALLY: The traditional use to facilitate parturition (childbirth) is NOT recommended as an indication in the monograph
• Basis: Long-standing traditional use (documented since at least the 6th century in Europe); insufficient clinical evidence

Agreement/Disagreement Between Bodies

• Universal caution on pregnancy use: No European regulatory body endorses Raspberry Leaf for pregnancy or labor facilitation
• Major disconnect with practice: Millions of women use Raspberry Leaf tea in pregnancy based on midwifery tradition, but no regulatory body supports this
• EMA assessment is the most developed: Provides formal traditional-use indications, but these are the non-pregnancy ones

Conditions Treated

EMA-Approved Traditional Uses

• Menstrual cramps (spasmodic period pains)
• Mouth and throat inflammation (gargle/rinse)
• Mild diarrhea

Traditional/Popular Uses (NOT Evidence-Based)

• Pregnancy preparation: “Toning” the uterus in late pregnancy
• Labor facilitation: Shortening labor, particularly second stage
• Postpartum recovery: Uterine involution support
• Morning sickness: Anecdotal use
• General uterine tonic: Non-specific traditional claim

Evidence Status of Popular Uses

• Pregnancy/labor: NOT supported by sufficient evidence; NOT endorsed by EMA
• Menstrual cramps: Traditional use accepted by EMA (plausible based on antispasmodic constituents)
• Mouth/throat: Traditional use accepted (tannin astringency provides rationale)

Mechanism of Action

Specific Compounds

Proposed Mechanism for Uterine Effects

1. Dual action on smooth muscle: In vitro and animal studies show both stimulatory AND relaxation effects on smooth muscle, depending on:
   • Type of preparation (aqueous vs. ethanolic)
   • Method of extraction
   • Type of tissue tested
   • Concentration
2. “Toning” hypothesis: Traditional practitioners propose that Raspberry Leaf does not simply stimulate contractions but “tones” the uterine muscle, making contractions more efficient when they occur
3. Fragarine’s role: Poorly studied; in vitro work suggests binding to smooth muscle receptors with a “mildly toning” effect on uterine fibers
4. Prostaglandin modulation: Flavonoids may inhibit COX enzymes, reducing prostaglandin synthesis responsible for uterine cramping

Critical Assessment

• Fragarine has never been fully characterized biochemically [NEEDS-RESEARCH]
• Active compounds could not be properly identified until Patel et al. (1995) suggested terpenes and/or alkaloids
• The dual stimulatory/relaxation effect makes prediction of clinical outcome difficult
• No established dose-response relationship in human uterine tissue
• Mechanism is, at best, speculative and based on limited pre-clinical data

Clinical Evidence Summary

Clinical Studies for Pregnancy/Labor

Key Limitations of Available Evidence

• No adequately powered RCT has been conducted
• Parsons et al. was retrospective with significant methodological limitations
• Simpson et al. was the only RCT but was small, and primary outcomes were not significant
• Bowman et al. was observational and explicitly warned against overinterpreting the safety data
• Publication bias: Negative results may be underreported given the strong cultural attachment to this remedy
• All researchers call for a rigorous RCT as urgently needed

Evidence for EMA-Approved Indications

• Menstrual cramps: No clinical trials; based on traditional use and plausible mechanism (antispasmodic flavonoids)
• Mouth/throat: No clinical trials; based on traditional use and tannin astringency
• Diarrhea: No clinical trials; based on traditional use and tannin astringency

European vs. US/Anglophone Consensus

Safety Profile

Contraindications

• Known hypersensitivity to Rubus idaeus or Rosaceae
• First trimester of pregnancy: Historically contraindicated (potential uterotonic effects before term)
• Complicated pregnancy: Should not be used in high-risk pregnancies, placenta previa, preterm labor risk

Drug Interactions

• No significant drug interactions documented in the literature
• Theoretical: Tannins may reduce absorption of iron supplements and some medications if taken concurrently (general tannin property)
• Atropine-like drugs: Theoretical interference based on smooth muscle effects [UNCERTAIN]

Side Effects

• At the time of the EMA assessment, no side effects had been reported
• Tannin overload: Possible constipation with excessive consumption
• Generally regarded as very safe within traditional dosage range
• One animal study (Zheng et al. 2010) indicated possible increased risk to the unborn — but this was a single animal study and has not been replicated [UNCERTAIN]

Pregnancy and Lactation — THE CENTRAL QUESTION

• Pregnancy: The most popular use, yet NOT recommended by any European regulatory body
  • No established safety data from controlled studies
  • Traditional use typically begins at 32-36 weeks (not earlier)
  • One animal study raised concerns; human observational data has not shown harm
  • Urgently needs a proper RCT (consensus of all researchers)
• Lactation: Traditionally considered safe; galactagogue properties claimed but unproven
  • No adverse effects reported
  • Tea consumption in normal dietary amounts likely safe

Important Clinical Guidance

The absence of observed harm in small observational studies should NOT be interpreted as evidence of safety. Healthcare providers should inform pregnant patients that Raspberry Leaf for labor preparation is NOT evidence-based and is NOT endorsed by European or American obstetric authorities.

Clinical Dosage

Traditional Dosage (for EMA-Approved Uses)

Traditional Pregnancy Dosage (NOT Evidence-Based)

Key Considerations

• No standardized extract with clinical validation exists
• Tea preparation: Most traditional and most commonly used form
• Tannin content varies with harvest time, drying method, and brewing time
• Product quality: Highly variable; no major pharmaceutical-grade products dominate the market

Connections

• Compare with Dong Quai — similarly weak evidence but for different reasons (failed monograph vs. traditional-only)
• Pregnancy safety is a unique concern among these herbs; most others are contraindicated in pregnancy, while Raspberry Leaf is specifically used in pregnancy
• For menstrual cramp relief, compare with Vitex Chasteberry which has stronger evidence via a different mechanism